Jason Drew Smith, General Counsel at UroGen Pharma Ltd. (URGN), sold 3,606 shares at $7.21 ($26K) on 2022-08-31, disclosed to the SEC on 2022-09-02.
Open-market sale of $26k URGN by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| URGN | SELL | 2025-09-09 | $29K | — | Filing → |
| URGN | SELL | 2025-07-30 | $288K | — | Filing → |
| URGN | SELL | 2025-02-04 | $82K | — | Filing → |